↑ Rising
Business
🔮 fades
The 'Best-Case Scenario' That Shot Arrowhead Stock Sky-High
Arrowhead Pharmaceuticals shares climbed following the release of positive late-stage clinical trial results for its drug candidate, plozasiran.